Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: Long‐term observation
- 15 March 2009
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 24 (4), 555-561
- https://doi.org/10.1002/mds.22390
Abstract
Stimulation of the subthalamic nucleus (STN) is an effective treatment for advanced Parkinson's disease (PD), but the medication requirements after implant are poorly known. We performed a long‐term prospective evaluation of 20 patients maintained at stable dopaminergic therapy for 5 years after bilateral STN implants, who were evaluated 6 months, 1 year, 3 years, and 5 years after surgery. We measured, during the entire observation period, the effect of deep brain stimulation on motor and functional outcome measures, the levodopa equivalent daily dose and the total electrical energy delivered. At 5 years, the UPDRS motor score had improved by 54.2% and levodopa equivalent dose was reduced by 61.9%, compared with preimplant. Dopaminergic medication remained stable during the observation period, but energy was progressively increased over time. Rest tremor, rigidity, gait, lower and upper limb akinesia, and total axial score were improved in decreasing order. Postural stability and speech improved transiently, whereas on‐period freezing of gait, motor fluctuations and dyskinesias recovered durably. Functional measures did not show improvement in autonomy and daily living activities after STN implant. Chronic STN stimulation allows to replace for dopaminergic medications in the long‐term at the expense of an increase of the total energy delivered. This is associated with marked improvement of motor features without a matching benefit in functional measures. © 2008 Movement Disorder SocietyKeywords
Funding Information
- Italian Ministry of University and Research
- National Interest Project (2001062543)
This publication has 24 references indexed in Scilit:
- Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulationParkinsonism & Related Disorders, 2008
- Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndromeClinical Neuropathology, 2007
- Long-Term Outcomes of Bilateral Subthalamic Nucleus Stimulation in Patients with Advanced Parkinson’s DiseaseStereotactic and Functional Neurosurgery, 2006
- Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomesMovement Disorders, 2006
- Calculating total electrical energy delivered by deep brain stimulation systemsAnnals of Neurology, 2005
- Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's DiseaseThe New England Journal of Medicine, 2003
- Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)Movement Disorders, 1999
- Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulationThe Lancet, 1995
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions?Neurology, 1987